Detection of Active Sacroiliitis with Ankylosing Spondylitis through Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging

[1] Braun J(1998)Radiologic diagnosis and pathology of the spondyloarthropathies Rheum Dis Clin N Am 24 697-735

[2] Bollow M(2005)Therapy of ankylosing spondylitis – a review Part I: Conventional medical treatment and surgical therapy Scand J Rheumatol 34 97-108

[3] Sieper J(2005)Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years Rheumatology 44 670-676

[4] Braun J(2006)Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria Arthritis Rheum 54 569-578

[5] Baraliakos X(1999)Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis J Rheumatol 26 980-984

[6] Godolias G(1986)Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis Br J Rheumatol 25 171-174

[7] Böhm H(2006)Assessments in ankylosing spondylitis Best Pract Res Clin Rheumatol 20 521-537

[8] Braun J(2009)Magnetic resonance imaging of active sacroiliitis: do we really need gadolinium? Eur J Radiol 71 232-236

[9] Baraliakos X(2008)Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging Skelet Radiol 37 123-131

[10] Brandt J(2010)Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI Ann Rheum Dis 69 648-653

[1] Braun J(1998)Radiologic diagnosis and pathology of the spondyloarthropathies Rheum Dis Clin N Am 24 697-735

[2] Bollow M(2005)Therapy of ankylosing spondylitis – a review Part I: Conventional medical treatment and surgical therapy Scand J Rheumatol 34 97-108

[3] Sieper J(2005)Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years Rheumatology 44 670-676

[4] Braun J(2006)Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria Arthritis Rheum 54 569-578

[5] Baraliakos X(1999)Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis J Rheumatol 26 980-984

[6] Godolias G(1986)Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis Br J Rheumatol 25 171-174

[7] Böhm H(2006)Assessments in ankylosing spondylitis Best Pract Res Clin Rheumatol 20 521-537

[8] Braun J(2009)Magnetic resonance imaging of active sacroiliitis: do we really need gadolinium? Eur J Radiol 71 232-236

[9] Baraliakos X(2008)Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging Skelet Radiol 37 123-131

[10] Brandt J(2010)Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI Ann Rheum Dis 69 648-653